RSPO3 and necrotizing enterocolitis: This study also revealed that amniotic fluid stem cells (AFSCs) exert protective effects on NEC progression through activation of the RSPO3/AMPKα signaling axis, indicating AFSCs application for NEC therapy in the clinical setting [84].